Themed Sections 2021

Vaccines

Health Economics of Vaccines: From Current Practice to Future Perspectives

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program

Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach

Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands

Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany

Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination

What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030

Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?

Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations

Opioid Misuse

Opioid Misuse: A Global Crisis

Incidence and Variables Associated With Inconsistencies in Opioid Prescribing at Hospital Discharge and Its Associated Adverse Drug Outcomes

Economic Evaluation in Opioid Modeling: Systematic Review

Cost-Effectiveness of an Opioid Abuse–Prevention Program Using the Narcotics Information Management System in South Korea

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis

Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries

Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review

Nutrition Economics

Nutrition Economics: Celebrating Cross-Disciplinary Collaboration

Childhood Nutrition in Rural China: What Impact Does Public Health Insurance Have?

A Systematic Review of Cost-Effectiveness Studies of Interventions With a Personalized Nutrition Component in Adults

When Industrial Policies Conflict With Population Health: Potential Impact of Removing Food Subsidies on Obesity Rates

COVID-19

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic

Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States

Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs

Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study

Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands

Where Do We Go From Here? A Framework for Using Susceptible-Infectious-Recovered Models for Policy Making in Emerging Infectious Diseases

Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic

Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories

Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review

Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios